Zum Inhalt springen
Teil von: S&P 100

CME Q1 2026 Earnings Analysis

CME Group | 7:05 | English | 4/22/2026

CME Group reported record 2024 results with $6.1B revenue (+10%) and $3.7B adjusted net income (+10%), driven by broad-based volume growth across all asset classes and geographies, with 2025 guidance including $1.65B operating expenses and fee increases expected to add 2%-2.5% to pre-tax income.

Key Metrics

2024 Revenue
$6.1B
+10% YoY
Adjusted Net Income
$3.7B
+10% YoY
Operating Margin
68.3%
+140 bps
ADV (2024)
26.9M contracts
+9% YoY
Q4 Revenue
$1.5B
+6% YoY
2025 Guidance (OpEx)
$1.65B
excl. license fees

Wichtigste Erkenntnisse

  • CME delivered record 2024 results with $6.1B revenue (+10%) and $3.7B adjusted net income (+10%), marking third consecutive year of double-digit earnings growth.
  • Fee adjustments effective Feb 1 and April expected to add 2%-2.5% to pre-tax income; transaction fees up 1%-1.5%, market data up 3.5%, plus 10 bps collateral surcharge.
  • Retail and international segments driving growth with new client acquisition generating ~$1B revenue over five years; commodities up 16% YoY with metals +23%, energy +17%, ags +13%.
Disclaimer: Financial metrics shown are extracted directly from the earnings call transcript. This is AI-generated content for educational purposes only. Not financial advice. Always verify data with official company filings.
CME Q1 2026 - English
0:00
7:05
Advertisement

Anhören auf

Verfügbar in

Transcript

// Full episode script

BETA FINCH PODCAST SCRIPT

A
Alex

Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest corporate earnings calls. I'm Alex, and I'm here with my co-host Jordan to dive into CME Group's Q4 2024 earnings. Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

J
Jordan

Thanks Alex. And wow, what a quarter for CME Group! This is a company that just keeps hitting records. We're talking about their fourth consecutive year of record volume with average daily volume up 9% to nearly 27 million contracts. Revenue hit $6.1 billion for the year - that's 10% growth - and they delivered their third straight year of record revenues and earnings.

A
Alex

It really is impressive. But what caught my attention was CEO Terry Duffy's comment about the blurring lines between retail and institutional trading. He said technology is equalizing access to data and improving information flow, bringing new types of traders into their markets. Jordan, what do you make of this trend?

J
Jordan

It's fascinating, Alex. They're seeing massive growth in their retail business - Julie Winkler mentioned that two-thirds of the $1 billion in revenue from new clients over the last five years came from retail. And get this - new client acquisition was up 23% year-over-year. They're even rolling out futures to Robinhood's 24 million customers, which could be a game-changer.

A
Alex

Speaking of game-changers, let's talk about their pricing power. CFO Lynne Fitzpatrick announced some interesting fee adjustments. Can you break that down?

J
Jordan

Sure thing. They implemented transaction fee adjustments in February that should boost futures and options revenue by 1% to 1.5%. They also raised market data fees by 3.5% and - this is clever - they're adding a 10 basis point surcharge for participants who don't post at least 30% of their margin in cash. In aggregate, these changes could add 2% to 2.5% to pre-tax income.

A
Alex

That cash requirement is smart risk management, especially given the current market environment. Terry Duffy was pretty candid about the economic headwinds ahead - $36 trillion in U.S. debt, geopolitical tensions, potential tariffs. He sees all of this driving demand for risk management tools.

J
Jordan

Exactly, and it's showing up in their commodities business, which was their third fastest-growing asset class. Metals volume up 23%, energy up 17%, agriculture up 13%. Derek Sammann pointed out they're seeing significant increases from global multi-strategy hedge funds expanding into commodity-focused strategies. This isn't just cyclical - it looks secular.

A
Alex

The international growth story is compelling too. Their EMEA commodities volume was up 34% year-over-year. But let's pivot to something that came up in the Q&A that I found intriguing - the regulatory environment under the new administration.

J
Jordan

Terry Duffy was pretty fired up about this, particularly around Treasury futures clearing. He made a strong case that having U.S. sovereign debt cleared overseas - specifically at LCH in the UK - poses systemic risks because the Bank of England would have resolution authority over a market larger than some countries' entire economies.

A
Alex

His quote was memorable: "If someone gets sick, we all get cancer" when talking about a $28 trillion market. Pretty stark warning. But shifting gears, what about their capital allocation strategy?

J
Jordan

They've got a new $3 billion buyback authorization, though Lynne Fitzpatrick described their approach as "opportunistic." They're still prioritizing their dividend - raised it from $1.15 to $1.25 - and they just paid out a $2.1 billion variable dividend in January. They're keeping their options open for M&A, but they're being selective.

A
Alex

Let's talk about their major technology investment - the Google Cloud migration. They spent $85 million in 2024 and are budgeting $115 million for 2025. That's a significant investment.

J
Jordan

It really is, Alex. They're migrating non-latency sensitive applications and working on additional capabilities for clients to use data more effectively. Combined with their market data business growing 9% to $182 million in Q4, they're clearly doubling down on technology and data as competitive advantages.

A
Alex

One thing that struck me in the Q&A was Terry Duffy's comment about looking over your shoulder to make sure there's a pipeline of clients coming. He seems very focused on customer acquisition and education, particularly in retail.

J
Jordan

That customer focus is paying off. They mentioned that their retail business is seeing increased sophistication - more options trading, more data usage. Non-professional device usage through their vendors was up almost 40% just from Q3 to Q4. These aren't just day traders anymore; they're becoming more sophisticated market participants.

A
Alex

Looking ahead to 2025, their guidance shows adjusted operating expenses of $1.65 billion and capex of around $90 million. The effective tax rate should be between 22.5% and 23.5%. Given their track record and the environment Terry described, how are you thinking about their prospects?

J
Jordan

I'm cautiously optimistic, Alex. They're benefiting from multiple tailwinds - increased market volatility, retail democratization, international expansion, and secular shifts in commodities trading. Their margin expansion story continues with operating margins at 68.3%. The big question is whether they can maintain this growth trajectory as they get larger.

A
Alex

The numbers certainly support continued momentum. They delivered 10% earnings growth for the third consecutive year, and volume is already off to a strong start in 2025 with records in January.

J
Jordan

Before we wrap up, I should note that everything we've discussed today is AI-generated analysis for educational purposes. Past performance doesn't guarantee future results. Please do your own due diligence.

A
Alex

Absolutely. CME Group continues to demonstrate the power of being the essential infrastructure for global risk management. As Terry Duffy noted, in an uncertain world, people need tools to manage and mitigate risk - and CME Group is positioned right at the center of that need.

J
Jordan

That's a wrap on today's Beta Finch breakdown. We'll be back next time with more AI-powered earnings analysis to help you stay informed about the markets that matter.

A
Alex

Thanks for listening, and remember - stay curious, stay informed, and always do your homework before making any investment decisions. --- *End of transcript*

Frequently Asked Questions

What was CME's 2024 revenue and earnings growth?
Revenue grew 10% to $6.1B; adjusted net income grew 10% to $3.7B with operating margin expanding 140 bps to 68.3%.
What pricing changes are expected in 2025?
Transaction fees +1%-1.5%, market data +3.5%, plus 10 bps collateral surcharge in April; combined expected to add 2%-2.5% to pre-tax income.
How much did new client acquisition contribute?
New clients added over five years generated ~$1B revenue, with ~5% of 2024 transaction and clearing revenue; two-thirds driven by retail.

Diese Episode teilen

Advertisement